An audit of medullary thyroid carcinoma from a tertiary care hospital in northwest India.

Journal: Frontiers in endocrinology
PMID: 38260132

Abstract

INTRODUCTION: Medullary thyroid carcinoma (MTC) is a rare thyroid malignancy originating from parafollicular C cells. It accounts for 5%-10% of all thyroid malignancies.

Authors

  • Ananda Mohan Chakraborty
    Department of Endocrinology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Ashutosh Rai
    Centre for Endocrinology, William Harvey Research Institute, Queen Marry University of London, London, United Kingdom.
  • Rimesh Pal
    Department of Endocrinology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Soham Mukherjee
    Department of Endocrinology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Divya Dahiya
    Department of General Surgery, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Rajinder Kumar
    Department of Nuclear Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Uma Nahar Saikia
    Department of Histopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Naresh Kumar Panda
    Department of Otorhinolaryngology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Sanjay Kumar Bhadada
    Department of Endocrinology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Pinaki Dutta
    Department of Endocrinology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Keywords

External Resources

Popular Topics
Recent Journals